Quest Diagnostics (DGX) Shares Outstanding (2009 - 2026)

Quest Diagnostics has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $111.0 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) fell 0.89% year-over-year to $111.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $111.0 million (down 0.89% YoY) and the FY2025 annual result came in at $111.0 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) improved to $111.0 million in Q2 2026 per DGX's latest filing, from $110.0 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $119.0 million in Q1 2022 and troughed at $110.0 million in Q1 2026.
• A 5-year average of $112.7 million and a median of $112.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) declined 10.53% in 2022, then rose 0.9% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $116.0 million in 2022, then slipped by 3.45% to $112.0 million in 2023, then retreated by 0.89% to $111.0 million in 2024, then changed by 0.0% to $111.0 million in 2025, then changed by 0.0% to $111.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $111.0 million, $110.0 million, and $111.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.